Table 1 Demographic data from all patients participating in the study.
Case | Age (years) | Sex | Subtype (DSM-IV) | Duration of illness (years) | Antipsychotic treatment, dosage |
|---|---|---|---|---|---|
1 | 56 | M | Schizophrenia, undifferentiated | 9 | Risperdal consta 25 mg/2w |
2 | 23 | F | Schizophrenia, undifferentiated | 3 | Leponex 700 mg/day, |
3 | 29 | M | Schizophrenia, unspecified | 8 | Risperdal 2 mg/day, Abilify 25 mg/day |
4 | 45 | M | Schizophrenia, paranoid | 6 | NA |
5 | 35 | M | Schizophrenia, unspecified | 11 | Leponex 200 mg/day, Abilify 15 mg/day |
6 | 54 | M | Schizophrenia, undifferentiated | 29 | Zyprexa 15 mg/day |
7 | 51 | M | Schizophrenia, paranoid | 23 | Leponex 100 mg/day, Abilify 10 mg/day |
8 | 56 | M | Schizophrenia, undifferentiated | > 15 | Zyprexa 10 mg/day, Cisordinol 140 mg inj 1/4w |
9 | - | - | - | - | - |
10 | 39 | F | Schizophrenia, paranoid | 8 | Risperdal 4 mg/day |
11 | 44 | M | Schizophrenia, unspecified | 26 | Leponex 800 mg/day, Abilify 10 mg/day |